Standout Papers

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascula... 2019 2026 2021 2023 795
  1. Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial (2019)
    David Fitchett, Silvio E. Inzucchi et al. Circulation
  2. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials (2020)
    Faı̈ez Zannad, João Pedro Ferreira et al. The Lancet

Immediate Impact

1 from Science/Nature 70 standout
Sub-graph 1 of 18

Citing Papers

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
2 intermediate papers

Works of Egon Pfarr being referenced

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
2020 Standout

Author Peers

Author Last Decade Papers Cites
Egon Pfarr 1334 558 480 715 24 1.7k
Sven Schnaidt 1454 527 503 604 22 1.8k
Anne Pernille Ofstad 1351 587 504 912 59 1.9k
Ira Gantz 1755 666 741 484 23 2.2k
Patrick Schloemer 1237 311 318 647 18 1.8k
Jenifer M. Brown 1349 950 268 798 61 2.1k
Silvina Gallo 1274 505 578 267 13 1.4k
Mikaela Sjöstrand 1066 443 433 790 49 1.8k
George L. Bakris 1186 298 313 579 10 1.7k
Egon Pfarr 1426 481 481 415 20 1.8k
Scott Krause 1823 647 389 1296 21 2.2k

All Works

Loading papers...

Rankless by CCL
2026